Christopher Reeve, the renowned actor left paralyzed after a horseback riding accident, underwent a groundbreaking procedure in Cleveland aimed at reducing his dependence on respirators for breathing.
University Hospitals in Cleveland revealed that doctors recently inserted electrodes into Reeve’s diaphragm as part of an experimental treatment to help him breathe independently without the aid of a respirator.
Since sustaining a neck injury eight years ago, Reeve has required assistance with breathing.
However, following the recent surgery, he has shown remarkable progress, now able to breathe unassisted for over two hours compared to just 10 minutes pre-surgery.
Dr. John McDonald, overseeing Reeve’s treatment, expressed optimism about the potential of the implanted electrodes to strengthen Reeve’s diaphragm muscles gradually, ultimately leading to self-sufficient breathing.
The procedure, conducted on February 28, is a pivotal step in Reeve’s journey toward improved respiratory function.
Speaking about the successful activation of Reeve’s diaphragm during the initial testing, Dr. Raymond Onders, the surgeon who performed the operation, highlighted the positive outcomes witnessed.
The contraction of the diaphragm resulted in efficient air intake and exhalation, indicating the viability of the device in providing effective breathing support.
Furthermore, Dr. Onders mentioned that besides aiding Reeve in breathing autonomously, the implant could enhance his speech capabilities and significantly reduce potential medical complications associated with prolonged ventilator use.
Reeve is among the select few to undergo this innovative procedure, known as diaphragm pacing via laparoscopy.
This minimally invasive technique involves inserting thin wires through small incisions in the diaphragm to connect to a control box outside the body, stimulating the diaphragm to contract rhythmically for proper air circulation in the lungs.
In a statement, Reeve emphasized the significance of diaphragm pacing in promoting independence for individuals with disabilities, underscoring the procedure’s potential to transform lives positively.
The alternative method, a thoracotomy, entails a more invasive approach involving chest surgery to attach electrodes directly to the nerves controlling breathing.
This traditional surgery, costing approximately $100,000, poses risks of nerve damage and requires an extended recovery period, unlike the less invasive procedure Reeve opted for, which can be performed on an outpatient basis at an estimated cost of around $50,000.
The research initiative funding Reeve’s surgery, a collaboration between the FDA, U.S. Surgical Corp., the Veterans Administration, and NIH, aims to expand the study to include more patients in the future.
The current project seeks additional funding to test the device on a larger scale, potentially benefitting a broader population of individuals with spinal cord injuries requiring respiratory support.
